Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC

NCT06551207 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Fruquintinib
DRUG: Cadonilimab
RADIATION: SBRT

Sponsor

Liu Huang